Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

Obesity pipeline

Studies

Trials grouped by drug. Open a study for its arms, the weeks a source actually reports, responder percents, and side effects.

624 studies across 92 of 94 drugs. 624 studies are in the file.

ABBV-2954 studies

ACCG-26711 study

Albiglutide6 studies

Aleniglipron8 studies

Apitegromab1 study

  • EMBRAZENCT06445075Phase 2Completedn 102

ARO-ALK71 study

ASC305 studies

AZD62346 studies

Beinaglutide1 study

Beloranib6 studies

Berobenatide12 studies

BGM05048 studies

Bimagrumab3 studies

Bofanglutide8 studies

Brenipatide1 study

Cagrilintide8 studies

Cagrilintide/semaglutide21 studies

Cetilistat1 study

Cotadutide2 studies

CRB-9131 study

  • CANYON-1NCT07310901Phase 1Completedn 254

CT-3888 studies

CT-8684 studies

CT-9961 study

DA-17261 study

Danuglipron2 studies

Dapiglutide2 studies

Dulaglutide11 studies

Ecnoglutide5 studies

Efinopegdutide1 study

Efpeglenatide5 studies

Efsubaglutide Alfa5 studies

Elecoglipron4 studies

Eloralintide14 studies

Eloralintide And Tirzepatide3 studies

Enobosarm2 studies

  • PLATEAUNCT07446998Phase 2Active, not recruitingn 239
  • QUALITYNCT06282458Phase 2Completedn 168

Exenatide15 studies

Garetosmab2 studies

GUB0142951 study

HDM10025 studies

HDM10058 studies

HDM17021 study

HM152112 studies

HS-200947 studies

LB546403 studies

Liraglutide30 studies

Lixisenatide3 studies

Lorcaserin6 studies

Lotiglipron6 studies

Loxenatide1 study

LY40869402 studies

Maridebart Cafraglutide17 studies

Mazdutide20 studies

MDR-0014 studies

MET-233I2 studies

Monlunabant3 studies

Naltrexone And Bupropion12 studies

Nimacimab1 study

  • CBeyondNCT06577090Phase 2Active, not recruitingn 136

NNC0165-18752 studies

NNC0519-01306 studies

Noiiglutide3 studies

Oral Semaglutide5 studies

  • OASIS 1NCT05035095Phase 3Completedn 667
  • OASIS 5NCT07770841Phase 3Recruitingn 450
  • OASIS 4NCT05564117Phase 3Completedn 307
  • OASIS 2NCT05132088Phase 3Completedn 201
  • OASIS 3NCT05890976Phase 3Completedn 200

Oral VK27354 studies

Orforglipron23 studies

Orlistat12 studies

Pemvidutide1 study

Petrelintide6 studies

PF-079760162 studies

Phentermine And Topiramate12 studies

Pramlintide12 studies

RAY12254 studies

Retatrutide13 studies

Ribupatide10 studies

Rimonabant10 studies

Safiglipron7 studies

Semaglutide37 studies

Setmelanotide15 studies

Sibutramine8 studies

Supaglutide5 studies

Survodutide21 studies

Taldefgrobep1 study

Taspoglutide1 study

TERN-6011 study

  • FALCONNCT06854952Phase 2Completedn 167

Tesofensine4 studies

TG1035 studies

Tirzepatide41 studies

UBT2518 studies

VCT2206 studies

Velneperit3 studies

Visepegenatide1 study

VK27353 studies

VRB-1013 studies

Zenagamtide6 studies